Pharma Leaders

MARCH 23, 2023

Dewpoint Therapeutics has formed a research and development partnership with Novo Nordisk for identifying drug candidates to treat insulin resistance and diabetic complications. Dewpoint’s discovery platform related to biomolecular condensates will be used to identify the drug candidates.

Diabetes 52

Diabetes 52

The Guardian - Pharmaceutical Industry

APRIL 9, 2023

He has championed a low-carb lifestyle that not only helps patients lose weight but also, in more than half of his patients who were on the diet, has even managed to reverse type 2 diabetes, once thought to be an irreversible and progressive disease. Continue reading.

Diabetes 98

Diabetes 98

Pharma Mirror

SEPTEMBER 27, 2021

The post Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin appeared first on Pharma Mirror Magazine. The DREAM study is an observational, non-pharmacologic and non-interventional clinical study initiated by certain researchers participating in the.

Diabetes 52

Diabetes Hospitals 52

ALiEM - Pharm Pearls

OCTOBER 20, 2023

A 50-year-old Caucasian female with a history of hypertension, coronary artery disease, and insulin-dependent diabetes mellitus presents to the emergency department with a complaint of painful sores on the top of her left foot. It may be equally common in patients without diabetes, hence was renamed without the term “diabeticorum”.

Diabetes 161

Diabetes 161

pharmaphorum

NOVEMBER 16, 2020

A new post-hoc analysis from Novo Nordisk of their SUSTAIN 6 and PIONEER 6 studies into semaglutide is looking to help ‘individualise’ treatment for diabetes patients by better predicting their cardiovascular lifetime risk. The two studies included 6,480 people with type 2 diabetes with high cardiovascular risk aged between 50-90 years.

Diabetes 70

Diabetes 70

STAT

JUNE 29, 2023

The American Society of Anesthesiologists issued guidance Thursday recommending that patients stop taking this class of treatments, called GLP-1 drugs, before undergoing surgery. Patients fast before surgery to prevent food from getting into their lungs while they’re under — a serious concern that can lead to lung infection.

Diabetes 253

Diabetes 253

STAT

OCTOBER 24, 2023

… European authorities asked four companies, including Novo Nordisk and Eli Lilly, to provide more information about possible anesthesia complications from weight-loss and diabetes drugs , Bloomberg News says. A European Medicines Agency committee made the request after a meeting in September.

Drug Pricing 223

Drug Pricing Diabetes 223

ALiEM - Pharm Pearls

SEPTEMBER 1, 2023

The most common pathogen is Klebsiella pneumoniae, and diabetes mellitus is the most common risk factor. Consider it especially in the patient with abdominal pain with diabetes mellitus. Additional Images Physical Exam Vitals : BP 172/71; HR 127; T 35.9°C; mmol/L; Glucose 538 mg/dL CRP : 42.6 mg/dL Ketone body : 5.9 mmHg; pO2 45.8

Diabetes 161

Diabetes Hospitals 161

The Guardian - Pharmaceutical Industry

MAY 14, 2024

Studies show active ingredient semaglutide can reduce the risk of heart attack, improve fertility and help treat diabetes It is a drug that has dominated headlines, first as a medication for type 2 diabetes, then as a weight-loss aid.

Diabetes 52

Diabetes 52

pharmaphorum

AUGUST 11, 2020

In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he hopes to bring the NHS and pharma together to improve outcomes in diabetes and other long-term conditions. Collaborating to prevent diabetes. These are massive societal burdens on countries,” says Sahota. Digital tools.

Diabetes 111

Diabetes Packaging Communication 111

The Guardian - Pharmaceutical Industry

MARCH 21, 2023

The three firms that control the insulin market are to cut costs in the US, but elsewhere users can spend all their pay to get the life-saving drug ‘I ration my insulin every month,” says Khushi Ahuja, a law student from Delhi who has type 1 diabetes and relies on human insulin manufactured by the US company Eli Lilly to manage her condition.

Diabetes 59

Diabetes Hospitals 59

STAT

MARCH 5, 2023

A two-part message is permeating the halls of medicine and the fabric of society, sliding into medical school lectures, pediatricians’ offices, happy hours and social feeds: Obesity is a chronic biological disease — and it’s treatable with a new class of medications. Read more about The Obesity Revolution.

Medical Schools 246

Medical Schools Drug Development Diabetes 246

ALiEM - Pharm Pearls

SEPTEMBER 15, 2023

Risk factors for the development of Dupuytren’s contracture include northern European descent, age greater than 50 years, and diabetes. Repetitive motion occupations, tobacco use, alcohol use, and diabetes are key risk factors. Case Question: What are the risk factors for this condition? References Shih B, Bayat A. Trojian TH, Chu SM.

Diabetes 152

Diabetes Clinic Management 152

STAT

JULY 5, 2023

… Novo Nordisk spent $11 million on meals and travel for thousands of doctors last year, federal records show, as part of its push to promote Ozempic and other weight loss-inducing diabetes drugs , STAT writes. The Some, such as the University of Tulsa in Oklahoma, are in states where abortion is largely banned. Over-the-counter

Diabetes 192

Diabetes 192

ALiEM - Pharm Pearls

AUGUST 18, 2023

The most common etiology of CN III palsy is ischemia of the nerve fibers secondary to diabetes mellitus or hypertension, which preferentially affects the internal somatic fibers that surround the blood supply. Case Question: What are the most common etiologies of the diagnosis? Surgical management of third nerve palsy. Oman J Ophthalmol.

Diabetes 130

Diabetes Communication 130

Safe Biologics

APRIL 11, 2023

The advocacy conference brought together patient advocates, health care providers, and industry representatives from the major national voluntary and professional societies concerned with digestive diseases. This year’s theme was “Improving Patient Care.”

Diabetes 100

Diabetes 100

ALiEM - Pharm Pearls

AUGUST 21, 2023

A 50-year-old male with a history of polysubstance use disorder and poorly-controlled type 2 diabetes mellitus presents with left hand pain. Risk factors for poor outcomes include immunocompromise (HIV, diabetes, immunosuppression), intravenous drug use, peripheral vascular disease, and polymicrobial infection. 2007;89(8):1742-1748.

Diabetes 130

Diabetes Hospitals 130

Putting Patients First Blog

APRIL 11, 2023

The Leukemia & Lymphoma Society WomenHeart The post 31 Patient and Provider Groups Warn that Mifepristone Ruling Threatens All FDA-approved Drugs appeared first on National Health Council. We support the FDA’s role in safeguarding patients and urge the Fifth Circuit Court of Appeals to act swiftly to reverse the judge’s decision.

Diabetes 75

Diabetes 75

ALiEM - Pharm Pearls

SEPTEMBER 25, 2023

66 year-old-male with a history of type 2 diabetes and hypertension presented as a transfer for rapid progression of lower extremity pain, swelling, and blue-purple discoloration of the entire limb with concern for a possible necrotizing infection. His symptoms began earlier in the day and progressed over just a few hours. doi: 10.5811/cpcem.2016.12.32716.

Medical Schools 152

Medical Schools Diabetes 152

Pharmaceutical Technology

JULY 22, 2022

Pipeline therapies within the diabetic macular oedema (DME) space have recently gathered interest following the American Society of Retina Specialists (ASRS) Annual Meeting, which took place on 13–16 July. They do need some VEGF. Constitutive expression of VEGF is important.”.

Diabetes 104

Diabetes Hospitals 104

Putting Patients First Blog

DECEMBER 18, 2023

Schubert , President & CEO, Society for Women’s Health Research Michael Ybarra , MD , Chief Medical Officer, PhRMA Sunita Mishra , MD , Chief Medical Officer, Amazin Health Services Michele M.

Diabetes 52

Diabetes Communication Immunity Immunization 52

The Guardian - Pharmaceutical Industry

JANUARY 14, 2024

A treatment for controlling epileptic seizures was the latest to be added on Wednesday to a UK drugs shortage list that includes treatments for conditions ranging from cancer to schizophrenia and type 2 diabetes. Continue reading.

Diabetes 110

Diabetes 110

European Pharmaceutical Review

NOVEMBER 7, 2022

Results from the EMPA-KIDNEY Phase III clinical trial announced at the American Society of Nephrology (ASN)’s Kidney Week 2022, demonstrated Jardiance ® (empagliflozin) reduced the risk of kidney disease progression or cardiovascular death by 28 percent versus placebo in adults with chronic kidney disease (CKD).

Diabetes 76

Diabetes 76

pharmaphorum

JANUARY 24, 2022

In November, NICE backed NHS use of AstraZeneca’s diabetes and heart failure drug Forxiga for the treatment of chronic kidney disease. It was initially developed for type 2 diabetes and was approved for this indication in 2014. The DAPA-HF and DAPA-CKD trials were launched, including patients with and without type 2 diabetes.

Diabetes 119

Diabetes 119

The Guardian - Pharmaceutical Industry

JANUARY 25, 2024

Mounjaro will come in a four-dose device known as a KwikPen for people with type 2 diabetes or obesity A new weight loss injection will be available in the UK within weeks to treat thousands of patients with type 2 diabetes or obesity, after the medicines watchdog became the first major regulator in the world to greenlight the drug in a more convenient (..)

Diabetes 47

Diabetes Pharmaceutical Companies Pharmaceutical Companies 47

ALiEM - Pharm Pearls

FEBRUARY 27, 2023

Septic arthritis of the facet joints is a rarity, particularly in pediatrics and in the cervical spine; case reports largely describe a lumbar location in elderly adults with predisposing comorbidities (intravenous drug use, diabetes, immunosuppression) for spontaneous infection. This patient developed septic arthritis following trauma.

Diabetes 161

Diabetes 161

ALiEM - Pharm Pearls

DECEMBER 8, 2023

Additionally, cardiovascular co-morbidities, such as obesity, hypertension, and diabetes, can increase the risk. Copyright Images and cases from the Society of Academic Emergency Medicine (SAEM) Clinical Images Exhibit at the 2023 SAEM Annual Meeting | Copyrighted by SAEM 2023 – all rights reserved. 2018 Apr;22(2):353-361.

Diabetes 152

Diabetes 152

PharmaShots

JANUARY 24, 2023

RGX-202 is intended to support the targeted delivery & expression of genes throughout skeletal & heart muscle using NAV AAV8 vector Ref: PRNewswire | Image: REGENXBIO Related News:- REGENXBIO Presents Interim P-II (ALTITUDE) Trial Results of RGX-314 for Diabetic Retinopathy Using Suprachoroidal Delivery at 55th Annual Retina Society Meeting (..)

Diabetes 40

Diabetes 40

Putting Patients First Blog

DECEMBER 12, 2023

Seven new members are joining the 2024 NHC Board of Directors: Charles Henderson , Chief Executive Officer, American Diabetes Association; Louise Vetter , President & Chief Executive Officer, Huntington’s Disease Society of America; Jorey Berry , President & Chief Executive Officer, Immune Deficiency Foundation; Kathryn G.

Diabetes 56

Diabetes Immunity Immunization 56

pharmaphorum

OCTOBER 25, 2022

Partha Kar, national specialty advisor on diabetes with NHS England, recently gave a presentation at the annual meeting of the European Association for the Study of Diabetes 2022 that centred on access. that covered whether breakthroughs in diabetes treatment and management were reaching all of those in need.

Diabetes 90

Diabetes Vaccines Medical Records Communication 90

PharmaShots

FEBRUARY 12, 2023

Patients in the two high-dose cohorts also showed stable to improved BCVA & CRT, and reductions in anti-VEGF burden & the results are being presented at the Angiogenesis, Exudation, and Degeneration 2023 conference NAVXpress platform process is incorporated in 2 ongoing pivotal trials & is expected to be used for future commercialization (..)

Diabetes 40

Diabetes 40

pharmaphorum

DECEMBER 1, 2020

First results of the DiabetRisk study – Over 8% of patients identified with undiagnosed diabetes or pre-diabetes at dental practices. The DiabetRisk study could contribute to early diagnosis of diabetes in thousands of dental patients each year – and in every country worldwide.

Diabetes 52

Diabetes Communication 52

PharmD Live

MAY 13, 2024

However, aging also brings about physiological and pathological changes that increase the risk of developing multiple chronic diseases, such as cardiovascular disease, stroke, and diabetes. Essentially, polypharmacy occurs when the use of multiple medications does more harm than good.

Long-Term Care Facilities 59

Long-Term Care Facilities Diabetes Nursing Homes Prescription Filling 59

ALiEM - Pharm Pearls

DECEMBER 4, 2023

Copyright Images and cases from the Society of Academic Emergency Medicine (SAEM) Clinical Images Exhibit at the 2023 SAEM Annual Meeting | Copyrighted by SAEM 2023 – all rights reserved. Penile Calciphylaxis in a Patient with End-stage Renal Disease: A Case Report and Review of the Literature. Open Med (Wars). 2018 May 9;13:158-163.

Hospitals 152

Hospitals Medical Schools Diabetes 152

PharmaShots

APRIL 20, 2023

Shots: Paul talked about the approval of the Lyumjev Injection for the improvement of glycemic control in children and adolescents with diabetes. Food and Drug Administration (FDA) in June 2020 as a rapid-acting insulin to improve glycemic control in adults with type 1 and type 2 diabetes. of the Lyumjev Injection.

Diabetes 40

Diabetes Labelling 40

pharmaphorum

FEBRUARY 28, 2022

The analysis by IQVIA and pharma company Chiesi looked at the per patient, per year (PPPY) direct, indirect and mortality-related costs associated with 24 rare diseases, and compared them to 24 chronic ailments like diabetes, heart disease, arthritis and cancers.

Inpatient 98

Inpatient Documentation Diabetes Hospitals 98

The Guardian - Pharmaceutical Industry

JANUARY 10, 2023

They can be associated with serious side effects such as sexual dysfunction, infertility, and weight gain leading to diabetes. The powerful drugs are often used to treat major mental illnesses, such as schizophrenia, in adults. Continue reading.

Diabetes 89

Diabetes 89